Article info

Download PDFPDF
Original research
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis

Authors

  1. Correspondence to Dr Francesco Patti, Department of Surgical and Medical Sciences Advanced Technologies GF Ingrassia, University of Catania, Catania 95126, Italy; patti{at}unict.it
View Full Text

Citation

Chisari CG, Grimaldi LM, Salemi G on behalf of the Italian MS Register Study Group, et al
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis

Publication history

  • Received April 16, 2020
  • Revised June 16, 2020
  • Accepted July 7, 2020
  • First published October 14, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.